628330-12-1

Upstream product

• 4724-10-1 methyl 2-(3,5-dihydroxyphenyl)acetate 
• 100-39-0 benzyl bromide 
• 77-78-1 dimethyl sulfate 
• 628330-11-0 (3-benzyloxy-5-methoxyphenyl)acetonitrile 
• 74-88-4 methyl iodide 
• 50637-26-8 methyl 3-(benzyloxy)-5-methoxybenzoate 
• 50637-28-0 (3-(benzyloxy)-5-methoxyphenyl)methanol 
• 2150-44-9 1-carbomethoxy-3,5-dihydroxybenzene 

Downstream Products

• 367259-04-9 (3-methoxy-5-hydroxy-phenyl)-acetic acid methyl ester 
• 272457-87-1 (R)-[3-(3-{(S)-[(R)-2-Benzyloxycarbonylamino-3-(4-methoxy-phenyl)-propionylamino]-methylcarbamoyl-methyl}-5-methoxy-phenoxy)-4-methoxy-phenyl]-tert-butoxycarbonylamino-acetic acid 
• 272457-86-0 [(R)-1-{[(S)-(3-Hydroxy-5-methoxy-phenyl)-methylcarbamoyl-methyl]-carbamoyl}-2-(4-methoxy-phenyl)-ethyl]-carbamic acid benzyl ester 
• 272457-85-9 2-amino-2-(3-hydroxy-5-methoxy-phenyl)-N-methyl-acetamide 
• 185342-10-3 (S)-Azido-(3-benzyloxy-5-methoxy-phenyl)-acetic acid 
• 185342-01-2 (S)-3-[(S)-2-Azido-2-(3-benzyloxy-5-methoxy-phenyl)-acetyl]-4-benzyl-oxazolidin-2-one 
• 185342-16-9 (S)-4-Benzyl-3-[2-(3-benzyloxy-5-methoxy-phenyl)-acetyl]-oxazolidin-2-one 
• 272457-84-8 (3-benzyloxy-5-methoxy-phenyl)-acetic acid 

Relevant academic research and scientific papers

Ruthenium-promoted diaryl ether synthesis in the construction of the F- O-G ring system of a teicoplanin model

An end-game approach is described for the synthesis of glycopeptide antibiotics related to teicoplanin, using ruthenium-promoted diaryl ether formation, followed by cycloamidation. (C) 2000 Elsevier Science Ltd.

1,2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY

A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, - O -, - S - and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents -OR4 (R4 is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.